ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.024,78
0,02%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
0,00%
Euro vs US Dollar
1,07145
-0,03%
Bitcoin
65.744,93
-1,34%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Organogenesis Holdings Inc (ORGO)

  7. Organogenesis Holdings Inc (ORGO) News

ORGO

Organogenesis (ORGO)

Organogenesis Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ORGO
DatumZeitQuelleÜberschriftSymbolFirma
06/06/202422h05GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
09/05/202422h25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGOOrganogenesis Holdings Inc
09/05/202422h05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
02/05/202413h00GlobeNewswire Inc.Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee OsteoarthritisNASDAQ:ORGOOrganogenesis Holdings Inc
16/04/202413h30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
03/04/202413h30GlobeNewswire Inc.Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseNASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202422h31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202422h05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 GuidanceNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202423h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202423h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202423h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202423h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202423h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
21/02/202402h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
21/02/202402h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
21/02/202402h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
21/02/202402h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
21/02/202402h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
12/02/202413h30GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
08/02/202422h05GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
02/02/202415h54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ORGOOrganogenesis Holdings Inc
09/01/202422h43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
09/11/202322h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGOOrganogenesis Holdings Inc
09/11/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
09/11/202322h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ORGO

Kürzlich von Ihnen besucht

FX
EURGBP
Euro vs Sterling
TG
MBG
MercedesBenz
NYSE
NKE
Nike
USOTC
BASFY
BASF (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
TG
NOV
Novo Nordisk
DBI
TDXP
Tec DAX
NYSE
MCD
McDonalds
CCOM
US100
US Tech 100
NASDAQ
GOOGL
Alphabet
CCOM
US30
US 30
USOTC
BNPQY
BNP Paribas (QX)
FX
EURJPY
Euro vs Yen
TG
DTE
Deutsche Telekom
COIN
SOLUSD
Solana
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten